Cancer Research UK logo.
SearchDonate
  • Search

A trial of idasanutlin with abiraterone or enzalutamide for men with prostate cancer who haven’t had docetaxel (MAdCaP)

Overview

Cancer types:

Prostate cancer

Status:

Closed

Phase:

Phase 1/2

Details

This trial is for men with prostate cancer that has spread and whose cancer no longer responds to hormone therapy. It is for men who haven’t had the chemotherapy drug docetaxel.

Cancer Research UK supports this trial.

Recruitment start: 4 August 2014

Recruitment end: 3 July 2017

How to join

Please note: In order to you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr Rob Jones

Supported by

Cancer Research UK

NHS Greater Glasgow and Clyde

NIHR Clinical Research Network: Cancer

Roche

University of Glasgow

Other information

This is Cancer Research UK trial number CRUKE/12/032.

Last reviewed: 11 Dec 2022

CRUK internal database number: 10085

Help and support